OTIC Otonomy Inc

Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear.

$1.84  -0.10 (-5.16%)
As of 05/20/2022 16:30:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/13/2014
Outstanding shares:  56,921,605
Average volume:  126,886
Market cap:   $110,427,914
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -4.01
PB ratio:   2.42
PS ratio:   0.00
Return on equity:   -90.02%
Net income %:   -111,231.50%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy